# Effect of Acetylcholinesterase Inhibitors on Bone Metabolism

> **NCT06041789** · PHASE2 · RECRUITING · sponsor: **Duke University** · enrollment: 45 (estimated)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** Donepezil
- **DRUG:** Memantine

## Key facts

- **NCT ID:** NCT06041789
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-03
- **Primary completion:** 2026-11
- **Final completion:** 2026-11
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2025-09-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06041789

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06041789, "Effect of Acetylcholinesterase Inhibitors on Bone Metabolism". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06041789. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*